Zepbound is a branded tirzepatide formulation. Tirzepatide is a dual GIP and GLP-1 receptor agonist, studied for its role in activating both GIP and GLP-1 receptor signaling and the downstream metabolic and appetite-related pathways associated with these receptors.

This branded formulation is used in controlled laboratory workflows and in-vitro systems examining GIP and GLP-1 receptor activity, appetite-related hormone signaling, and glucose-regulation mechanisms. It is applied in structured research models characterizing receptor activity and downstream pathway interactions.

Zepbound supports analytical studies and cell-based models involving dual GIP/GLP-1 receptor agonism, satiety signaling, insulin- and glucose-related pathways, and broader metabolic efficiency. It is relevant for pathway characterization and assay development focused on endocrine and metabolic cross-talk within controlled study frameworks.

Zepbound is suited for researchers and investigators who require a branded, standardized tirzepatide reference when studying dual-incretin receptor signaling and metabolic-regulation mechanisms within controlled study frameworks.